PROVECTUS BIOPHARMACEUTICALS, INC. Total Liabilities and Equity
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) had Total Liabilities and Equity of $1.47 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-13
- 2026-06-30: Liabilities and Equity $1.47M.
- 2026-03-31: Liabilities and Equity $577.58K.
- 2025-12-31: Liabilities and Equity $697.50K.
- 2025-09-30: Liabilities and Equity $419.90K.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $1.47M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $577.58K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $697.50K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $419.90K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $722.38K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $666.26K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.01M 10-K · filed 2026-03-26 |
| 2024-09-30 | $802.03K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $856.43K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.08M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.45M 10-K · filed 2025-03-28 |
| 2023-09-30 | $1.69M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.69M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.72M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $2.04M 10-K · filed 2024-03-28 |
| 2022-09-30 | $2.05M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $2.44M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $2.76M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.51M 10-K · filed 2023-03-30 |
| 2021-09-30 | $600.34K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $466.30K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $771.42K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $589.20K 10-K · filed 2022-03-29 |
| 2020-09-30 | $1.34M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.84M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $819.96K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $1.48M 10-K · filed 2021-03-02 |
| 2019-09-30 | $1.56M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.72M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $3.69M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $1.99M 10-K · filed 2020-03-05 |
| 2018-09-30 | $2.42M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $3.53M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $3.06M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $3.44M 10-K · filed 2019-03-07 |
| 2017-09-30 | $3.85M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $4.93M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $4.51M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $5.61M 10-K · filed 2018-03-23 |
| 2016-09-30 | $10.69M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $10.83M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $16.02M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $20.44M 10-K · filed 2017-03-31 |
| 2015-09-30 | $26.60M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $31.24M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $22.77M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $26.18M 10-K · filed 2016-03-30 |
| 2014-09-30 | $21.65M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $22.10M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $20.79M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $20.01M 10-K · filed 2015-03-12 |
| 2013-09-30 | $12.78M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $9.37M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $9.27M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $6.20M 10-K · filed 2014-03-13 |
| 2012-09-30 | $7.01M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $9.47M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $10.45M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $13.35M 10-K · filed 2013-03-14 |
| 2011-09-30 | $16.67M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $20.47M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $14.40M 10-K · filed 2012-03-14 |